Michael J. Cork

educated at: British Association of Dermatologists, University of St Andrews

occupation: researcher

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 117

Date

Title

Authors

2020-03-29

European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis

Andreas Wollenberg, Michael J. Cork, Magdalena Trzeciak
2020-07-15

An Investigation of the Skin Barrier Restoring Effects of a Cream and Lotion Containing Ceramides in a Multi-vesicular Emulsion in People with Dry, Eczema-Prone, Skin: The RESTORE Study Phase 1

Simon G Danby, Michael J. Cork
2020-07-16

Vehicles for atopic dermatitis therapies: more than just a placebo

Simon G Danby, Zoe Diana Draelos, Linda F Stein Gold, Amy Cha, Bonnie Vlahos, Michael J. Cork
2020-09-30

Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)

Andreas Wollenberg, Andrew Blauvelt, Emma Guttman-Yassky, Margitta Worm, Lynda Spelman, Norito Katoh, Michael J. Cork
2020-02-19

Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial

Michael J. Cork, Tracey Sach, Michael R Perkin
2019-10-08

Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extension

Michael J. Cork, Peter D Arkwright, Bolanle Akinlade, Laurent Eckert, Ashish Bansal
2019-10-21

Atopic dermatitis epidemiology and unmet need in the United Kingdom

Michael J. Cork, Graham Ogg
2019-12-02

Diaper dermatitis prevalence and severity: Global perspective on the impact of caregiver behavior

Andrew N Carr, Michael J. Cork, Lawrence F Eichenfield, Alain Taieb, Zigang Xu
2019-05-06

Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinion

Christian Vestergaard, John C. Su, Michael J. Cork
2019-05-07

Conjunctivitis in dupilumab clinical trials

Bolanle Akinlade, Emma Guttman-Yassky, Marjolein de Bruin-Weller, Andrew Blauvelt, Michael J. Cork, John D Davis
2019-03-12

Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey-based position statement

Carle Paul, Alan D. Irvine, Michael J. Cork
2019-08-26

Genotype-phenotype correlation in a large English cohort of patients with autosomal recessive ichthyosis

Jacqueline Simpson, Alexandros Onoufriadis, Simon Tso, Toshihide Higashino, Amir Hossein Saeidian, Hassan Vahidnezhad, Alessandra Bisquera, Edel O'Toole, Michael J. Cork, John Mcgrath
2019-06-09

Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2

Michael J. Cork, Sébastien Barbarot, Luis Puig
2019-08-20

Protocol for an outcome assessor-blinded pilot randomised controlled trial of an ion-exchange water softener for the prevention of atopic eczema in neonates, with an embedded mechanistic study: the Softened Water for Eczema Prevention (SOFTER) trial

Kim Thomas, John Common, Michael J. Cork
2019-06-23

European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period

Christian Vestergaard, Magdalena Trzeciak, Carle Paul, Michael J. Cork, Pavel V Chernyshov
2018-08-01

Response to "Comment on: 'When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council'"

Nick J Reynolds, Michael J. Cork, Alan D. Irvine, Emma Guttman-Yassky
2018-07-12

Infant Skin Barrier, Structure, and Enzymatic Activity Differ from Those of Adult in an East Asian Cohort

Michael J. Cork, Georgios N Stamatas
2018-08-21

pH in Atopic Dermatitis

Michael J. Cork
2018-03-25

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)

Marjolein de Bruin-Weller, Michael J. Cork
2018-03-29

Sub-clinical assessment of atopic dermatitis severity using angiographic optical coherence tomography.

Robert A Byers, Michael J. Cork, Matt J Carré, Roger Lewis, Raman Maiti, Simon G Danby
2017-06-01

Computational design of treatment strategies for proactive therapy on atopic dermatitis using optimal control theory

Yoshito Hirata, Elisa Domínguez-Hüttinger, Michael J. Cork, Reiko J Tanaka
2017-07-21

Effectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (The BEEP trial): protocol for a randomised controlled trial

Joanne Chalmers, Rachel H Haines, Eleanor Mitchell, Kim Thomas, Matthew J. Ridd, Michael J. Cork, Tracey Sach, Robert Boyle
2017-06-14

Comparison of the Simple Patient-Centric Atopic Dermatitis Scoring System PEST with SCORAD in Young Children Using a Ceramide Dominant Therapeutic Moisturizer

Mark Jean-Aan Koh, James Mason, Michael J. Cork
2017-08-10

When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council

John C. Su, Sébastien Barbarot, Christian Vestergaard, Michael J. Cork, Audrey Nosbaum, Nick J Reynolds, Jacob Pontoppidan Thyssen, Alan D. Irvine, Emma Guttman-Yassky, Claudia Traidl-Hoffmann
2017-09-01

Erratum to: Comparison of the Simple Patient-Centric Atopic Dermatitis Scoring System PEST with SCORAD in Young Children Using a Ceramide Dominant Therapeutic Moisturizer

Mark Jean-Aan Koh, James Mason, Michael J. Cork
2017-09-12

The Effect of Water Hardness on Surfactant Deposition after Washing and Subsequent Skin Irritation in Atopic Dermatitis Patients and Healthy Control Subjects.

Simon G Danby, John Chittock, Michael J. Cork
2017-09-01

The British Skin Foundation: 20 years of supporting dermatology research

Michael J. Cork
2016-04-21

A functional mechanistic study of the effect of emollients on the structure and function of the skin barrier.

Simon G Danby, Joanne Chalmers, Michael J. Cork
2016-07-14

Vitamin D and antimicrobial peptide levels in patients with atopic dermatitis and atopic dermatitis complicated by eczema herpeticum: A pilot study

John Chittock, Michael J. Cork
2016-06-02

The Effect of an Emollient Containing Urea, Ceramide NP, and Lactate on Skin Barrier Structure and Function in Older People with Dry Skin

John Chittock, Michael J. Cork
2016-07-22

Development of stratum corneum chymotrypsin-like protease activity and natural moisturizing factors from birth to 4 weeks of age compared with adults

John Chittock, Alison Cooke, Michael J. Cork, Simon G Danby
2016-09-30

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.

Michael J. Cork, Jean-Philippe Lacour, Külli Kingo, Margitta Worm, Andrew Blauvelt, Emma Guttman-Yassky

Human - wd:Q44605049

Welcome to Inventaire

the library of your friends and communities

learn more